欧洲法院撤销了欧盟委员会阻止 Illumina 收购 $7.1B Grail 的禁令，限制了欧盟监管较小合并的能力。 European Court annulled EU Commission's block of Illumina's $7.1B Grail acquisition, limiting EU's ability to regulate smaller mergers.
欧洲法院裁定欧盟委员会超越了其权力, 试图阻止Illumina以71亿美元收购癌症诊断公司Grail. The European Court of Justice ruled that the European Commission overstepped its authority by trying to block Illumina's $7.1 billion acquisition of Grail, a cancer diagnostic company. 法院废除了委员会判处的4.32亿欧元罚款,并澄清说,欧盟不能审查缺乏大量欧洲收入的兼并。 The court annulled a €432 million fine imposed by the Commission and clarified that the EU cannot review mergers lacking significant European revenue. 这一具有里程碑意义的决定限制了欧盟管制较小的收购的能力,并可能导致关于竞争法的讨论。 This landmark decision limits the EU's ability to regulate smaller takeovers and may lead to discussions on competition laws.